[ET Net News Agency, 16 September 2024] AKESO (09926) rose 13.9% to HK$70.25.
It hits an intra-day high of HK$70.5, hitting a historical high, and an intra-day low of
HK$65.1. The total shares traded was 8.16 million, with a value of HK$544.37m. The active
buy/sell ratio is 54:46, with net buying turnover of HK$36.75m. CLSA LTD accounts for
greatest net responsive buying turnover of HK$30.85m, with volume weighted average price
of HK$66.65. MORGAN STANLEY HK SEC accounts for greatest net responsive selling turnover
of HK$27.63m, with volume weighted average price of HK$66.348. The stock has risen a
combined 24.8% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 70.250 % Chg +13.95%
High 70.500 Low 65.100
Shares Tr 8.16m Turnover 544.37m
10-D SMA 55.410 %H.V 69.960
20-D SMA 50.960 VWAP 66.692
50-D SMA 45.122 RSI14 83.637
----------------------------------
Status: Hitting a historical high, active buy/sell ratio is 54:46, with net buying
turnover of HK$36.75m, rising a combined 24.8% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
AKESO (09926) 70.25 +13.95
IMMUNEONCO-B (01541) 6.80 +37.65
EVEREST MED-B (01952) 22.00 -6.38
KEYMED BIO-B (02162) 38.35 -3.52
WUXI XDC (02268) 20.10 Unchanged
ASCENTAGE-B (06855) 33.20 -0.75
SKB BIO-B (06990) 181.50 -0.77
ZAI LAB (09688) 16.12 +0.62
INNOCARE (09969) 5.57 -3.47
REMEGEN (09995) 10.94 -15.19
---------------------------------------------
(ed)